TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
SDS Life Science AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
6,507
|
7,163
|
7,171 |
| Financial expenses |
0
|
60
|
126 |
| Earnings before taxes |
698
|
-305
|
-223 |
| EBITDA |
753
|
-175
|
-98 |
| Total assets |
3,519
|
2,535
|
2,712 |
| Current assets |
3,198
|
2,150
|
2,375 |
| Current liabilities |
1,369
|
1,159
|
1,197 |
| Equity capital |
782
|
241
|
95 |
| - share capital |
17
|
18
|
18 |
| Employees (average) |
42
|
50
|
45 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
22.2%
|
9.5%
|
3.5% |
| Turnover per employee |
155
|
143
|
159 |
| Profit as a percentage of turnover |
10.7%
|
-4.3%
|
-3.1% |
| Return on assets (ROA) |
19.8%
|
-9.7%
|
-3.6% |
| Current ratio |
233.6%
|
185.5%
|
198.4% |
| Return on equity (ROE) |
89.3%
|
-126.6%
|
-234.7% |
| Change turnover |
-412
|
-29
|
1,144 |
| Change turnover % |
-6%
|
0%
|
19% |
| Chg. No. of employees |
-8
|
5
|
11 |
| Chg. No. of employees % |
-16%
|
11%
|
32% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.